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Abstract
Background: Neonatal leukemia is a rare disease with an estimated prevalence of about one to five in a million
neonates. The majority being acute myeloid leukemia (AML), neonatal leukemia can present with a variety of
symptoms including hyperleucocytosis, cytopenia, hepatosplenomegaly, and skin infiltrates. Chromosomal
rearrangements including mixed lineage leukemia (MLL) translocations are common in neonatal AML.
Case presentation: A female neonate born at 34 weeks gestation presented with cardiorespiratory failure,
hepatosplenomegaly, pancytopenia, and coagulopathy. She required intensive care treatment including mechanical
ventilation, high-dose catecholamine therapy, and multiple transfusions. Small intestinal biopsy obtained during
laparotomy for meconium ileus revealed an infiltrate by an undifferentiated monoblastic, MLL-rearranged leukemia.
No other manifestations of leukemia could be detected. After spontaneous clinical remission, lasting 5 months
without any specific treatment, the patient presented with leukemia cutis and full-blown monoblastic leukemia.
MLL-AF10-rearranged AML could be re-diagnosed and successfully treated with chemotherapy and hematopoietic
stem cell transplantation.
Conclusions: Our patient exhibited a unique manifestation of neonatal MLL-AF10 rearranged AML with
cardiorespiratory failure and intestinal infiltration. It highlights the importance of leukemia in the differential
diagnosis of neonatal distress, congenital hematological abnormalities, and skin lesions.
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Acute myeloid leukemia (AML) accounts for about 18 %
of pediatric leukemias [1]. Disease onset during the neo-
natal period is extremely rare, with an estimated preva-
lence of one to five in a million neonates. The majority of
neonatal leukemias are AML, and the most common type
is monoblastic leukemia (FAB M5). Typical clinical
features are skin infiltrations, hepatosplenomegaly, and
cardiac failure. Prenatal symptoms including non-immune
hydrops and polyhydramnios illustrate the in utero origin
of the disease [2]. Like in infant leukemias, chromosomal
rearrangements are regularly found in neonatal leukemias
[2, 3] with chromosome 11q23/MLL rearrangements be-
ing by far the most common ones. [4].
Case report
We present the case of a 14-month-old girl from birth
until today. Pregnancy was uneventful until 34 weeks
gestation, when polyhydramnios, pathological cerebral
Doppler flow, pleural effusions, and pathological cardio-
tocography led to performing a cesarean section. The
girl was born pale, with no muscle tone, no spontaneous
breathing, and bradycardia. The APGAR score was 2/6/7
at 1/5/10 min. Persisting respiratory insufficiency required
maximally invasive treatment including the administration
of endotracheal surfactant, the use of a high-frequency
oscillation ventilator and nitrogen monoxide to main-
tain sufficient oxygenation. Continuous dobutamine
and adrenaline infusions were necessary due to severe
circulatory deterioration starting immediately after
birth. Echocardiogram revealed pulmonary hyperten-
sion and compromised right ventricular function.
Massive hepatosplenomegaly was detectable on abdom-
inal ultrasound.
An initial hemoglobin value of 6.3 g/dl led to an
emergency erythrocyte transfusion, and further erythro-
cyte transfusions were necessary in the first weeks of
life. Multiple petechiae and suggilations were present at
birth, thrombocytopenia and disseminated intravascular
coagulopathy with unmeasurable thrombin time repeat-
edly required multiple thrombocyte concentrate and
fresh-frozen plasma transfusions. An initial leukocyte
count of 45.000/μl rapidly dropped to a minimum of
600/μl.
The etiology of the clinical condition with cardiorespi-
ratory failure, pancytopenia, and disseminated intravas-
cular coagulopathy together with skin hemorrhages and
hepatosplenomegaly was at first elusive. Ganciclovir was
initiated for suspected cytomegalovirus infection but
withdrawn following negative results. Given the possibility
of neonatal sepsis, various antibiotics and fluconazole
were administered, but inflammatory values did not mark-
edly increase and microbiological cultures and extensive
viral PCR studies yielded exclusively negative results.
Peripheral blood smears from the fourth day of life
revealed immature monocytic cells, and bone marrow
puncture was found unrepresentative without evidence of
blastic cells. Additional flow cytometry was unremarkable.
Genetic predisposition for hemophagocytic lymphohistio-
cytosis was excluded.
The girl’s clinical condition remained highly instable,
when on the tenth day of life the assessment of acute
abdomen required explorative laparotomy. During sur-
gery, a meconium ileus was found that could only be
resolved by establishment of an ileostomy. Because of a
massively distended abdomen, abdominal closure could
only be realized by placement of a patch. Buccal mu-
cosa and ileum biopsies were undertaken to exclude
neonatal hemochromatosis.
Unexpectedly, pathological examination revealed dif-
fuse submucosal infiltration by polymorphous, atypical
cells suspicious of Langerhans cell histiocytosis (LCH).
Single-shot treatment with vincristine (0.05 mg/kg) and
prednisolone (1.5 mg/kg/d) for suspected LCH was im-
mediately commenced. Five days later, the LCH diagno-
sis was rejected by reference pathology evaluation and
reclassified as completely undifferentiated blastic trans-
mural infiltration with diffuse growth pattern, positive
staining for CD68, partial expression of S100, negative
staining for langerin, lysozyme, CD1a, myeloperoxidase,
CD34 ,and CD30, and an increased proliferation rate of
80 % (MIB1) (Fig. 1).
To further classify the blastic infiltration, additional
immuno-histochemical staining was performed and re-
vealed partial expression of CD163, negativity for CD56,
CD117, CD3, CD79a, desmin, NB84, pan-cytokeratin,
synaptophysin, and TdT, and preserved nuclear expres-
sion of INI1, thus being consistent with an undifferenti-
ated leukemia with partial monoblastic differentiation.
Further, a chromosomal breakpoint at the mixed lineage
leukemia (MLL) locus 11q23 could be detected by fluores-
cence in situ hybridization (FISH, LSI MLL Dual Color,
Break Apart Probe, Abbott) substantiating the diagnosis of
an undifferentiated, MLL positive leukemia. Two subse-
quent bone marrow punctures at the age of 3 and
5 weeks did not show any signs of leukemia, and no
MLL rearrangement could be detected by FISH (Table 1).
Subsequently, leukocyte, erythrocyte, and thrombocyte
counts recovered spontaneously, accompanied by gradual
clinical improvement including complete weaning from
ventilator support and reversal of ileostomy. The patient
was discharged at 6 weeks of age and a weight of 2900 g
in excellent clinical condition.
Subsequent clinical follow-up displayed regular weight
gain (weight at birth 3000 g, at the age of 6 weeks
2900 g, at 3 months 4300 g) and development and
routine hematological controls remained unremarkable.
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Five months later, while on treatment for hemangioma
with propranolol, suspicious, blue-berry muffin-like skin
lesions were noted on clinical examination. Leukocyte
count was 28.500/μl, and thrombocyte and erythrocyte
counts were normal. Monoblastic leukemia (AML FAB
M5) was diagnosed from peripheral blood and bone
marrow (Fig. 2). An MLL-AF10 fusion transcript was
detected by real-time and nested PCR. Retrospective
analyses (by nested PCR) at the time point, when bone
marrow sampled in the third week of life was MLL-
rearrangement-negative by FISH, showed that the MLL-
AF10 fusion transcript was already detectable back then,
4 months prior to the definitive diagnosis of AML in the
bone marrow (Table 1).
Chemotherapy was initiated according to the German
AML-BFM 2012 study protocol [5]. Due to the MLL-
AF10 rearrangement, the patient was classified as “high
risk” and consequently qualified for hematopoietic stem
cell transplantation (hSCT). The patient received one
block of induction and two blocks of consolidation
chemotherapy. Subsequently, the patient underwent
hSCT from an unrelated, HLA-matched donor. The
conditioning regimen consisted of busilvex, cyclophos-
phamide, melphalan, and anti-thymocyte globuline
(ATG). Cyclosporin A and methotrexate were adminis-
tered as prophylaxis against Graft versus Host Disease
(GvHD). Leukocyte engraftment was detected at day 19,
granulocyte engraftment at day 23 post transplantation.
Chemotherapy and stem cell transplantation were well
tolerated under supportive care. The girl was discharged
at day +60. Apart from partial compromise of renal
function, no significant complications occurred. Until
now, the patient is well, relapse-free, and showing no
signs of GvHD 9 months after transplantation. Donor
chimerism is 100 %.
Discussion
Neonatal leukemia is extremely rare. It accounts for about
1 % of pediatric leukemias and has an estimated preva-
lence of one to five in a million neonates. The disease was
already known in the early twentieth century [6]. Neonatal
AML shows similarities to transient myeloproliferative
disorder (TMD), an abnormal proliferation of myeloid
blasts observed in Down’s syndrome that usually resolves
without therapy [7]. A few cases with spontaneous remis-
sion, which in one case was transient, mimicking TMD of
Down syndrome, have been described in neonates with
Fig. 1 Submucosal infiltrate of polymorphic, atypical cells in the terminal ileum. Top row: ×25 magnification, bottom row: ×400 magnification.
Left: hematoxylin and eosin (H&E) stain. Middle: KI67 staining shows a proliferation rate of 80 %. Right: the majority of cells display positive staining
for the monocyctic marker CD68. A clonal MLL breakpoint in 11q23 was detected by FISH on paraffin embedded tissue-slides in the cells of the
intestinal infiltrate. The population was classified as an extramedullary manifestation of monoblastic acute myeloid leukemia (AML FAB M5)




Ileum biopsy 10 days FISH MLL
rearrangement
Positive
Bone marrow 3 weeks FISH MLL
rearrangement
Not feasible
Nested PCR MLL-AF10 Positive
(in retrospect)
Bone marrow 5 weeks FISH MLL
rearrangement
Negative








Bone marrow 5 months RT-PCRa MLL-AF10 Positive
aQuantitative real time PCR
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normal karyotypes [2, 8, 9]. Isolated leukemia cutis has
also been described to disappear spontaneously [10, 11].
However, to the best of our knowledge, no case of a pre-
term baby with persistent pulmonary hypertension
(PPHN) and cardiorespiratory failure requiring NO-based
artificial ventilation and high-dose catecholamines could
successfully be rescued by combined efforts of intensive
care, chemotherapy, and stem cell transplantation.
The clinical picture of neonatal leukemia is variable.
Common symptoms include leukocytosis, cytopenia,
hepatosplenomegaly, and skin infiltrations. The latter are
known as leukemia cutis, appear in about 60 %, and are
the first symptom in about one half of neonatal leukemia
cases. Leukemia cutis, presenting as firm nodules, pap-
ules or plaques of red, blue or purple color, is a differen-
tial diagnosis of the so-called blueberry muffin baby.
This syndrome has a diversified differential, ranging
from hemato-oncological disorders like Langerhans cell
histiocytosis, neuroblastoma, or rhabdomyosarcoma to in-
fectious diseases like rubella, cytomegalovirus infection, or
toxoplasmosis to hemolytic disease and blue rubber bleb
nevus syndrome [12, 13]. Leukemia cutis has been de-
scribed as an exclusive manifestation of AML without
bone marrow disease [14], as well as appearing prior to or
simultaneously with bone marrow involvement [13, 15].
Our patient presented with severe bruising at birth, prob-
ably due to thrombocytopenia and coagulopathy. Months
later after presumed relapse of the so far not unequivo-
cally diagnosed AML, she primarily presented with skin
infiltrations.
As a hematological malignancy, leukemia is essentially a
distributed disease, but primary presentation as extrame-
dullary infiltration, also called myeloid sarcoma, is a rarity
in AML. Pediatric myeloid sarcoma has a prevalence of
about 0.7 in one million children and can progress to
AML [16, 17]. Infiltration of the gastrointestinal tract, in-
cluding the ileum, has been reported in AML [18, 19]. In
our patient, acute meconium ileus appeared on the tenth
day of life. An extensive infiltration of monoblasts was
found as the probable cause of the mechanical ileus. To
our knowledge, such a condition has also not yet been
described in neonatal leukemia.
Chromosome 11q23 rearrangements involving the
MLL gene locus are common in infant leukemia; they
are the most frequent finding in neonatal AML [2]. Spe-
cifically, our patient had an MLL-AF10 fusion transcript,
which is rather rarely found among the large variety of
the various MLL rearrangements [20]. In the AML-BFM
2012 protocol, MLL-AF10 positive patients are consid-
ered “high risk” and recruited to a treatment protocol
including hSCT. In our patient, a MLL rearrangement
was first diagnosed from the intestinal infiltrate found in
the terminal ileum and a MLL-AF10 fusion transcript
was first detected at 5 months of age. In retrospect, its
presence could then be verified from the bone marrow
obtained at the age of 3 and 5 weeks by a sensitive PCR
assay.
As from the first days of life there is no more material
available, it remains somehow unclear of what extent the
leukemia initially presented and whether the cytopenia
was due to bone marrow involvement or whether it was
associated to cytokine release and/or coagulopathy. In
the following weeks, the clinical condition improved and
no signs of leukemia could be detected. It cannot be
ruled out with certainty that regression of the leukemia
was not spontaneous but caused by a single dose of
vincristine and prednisolone treatment; however, given
the prolonged recovery, the latter seems unlikely. Thus,
other reasons for spontaneous regression of this aggres-
sive type of leukemia, such as infection or disease related
cytokine release, should be considered.
Taken together, these findings indicate that our patient
had a neonatal, MLL-AF10 positive AML with spontan-
eous transient regression that later reappeared as leukemia
cutis and bone marrow disease.
Conclusion
We present a unique manifestation of neonatal MLL-
AF10 positive AML with cardiorespiratory failure at
birth, intestinal infiltration, and skin involvement. After
a transient spontaneous regression, the patient was suc-
cessfully treated by chemotherapy and hSCT and is alive
and well.
Fig. 2 Monoblastic leukemia (AML FAB M5) (×63 magnification) diagnosed from peripheral blood (left) and bone marrow (right) at the age of 5 months
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